Saputo to make its British entrance with acquisition of Dairy Crest

By Nikita Chaurasia  Date: 2019-02-24

Saputo to make its British entrance with acquisition of Dairy Crest

Dairy Crest plans to advise its shareholders to vote in favor of the deal as it considers the terms of the deal to be fair and reasonable.

Saputo Inc., a Montreal-based Canadian dairy company, has entered the British market with an agreement to buy Dairy Crest Group Plc., a leading British dairy products company. The deal has reportedly been finalized at £975 million ($1.27 billion).

For Saputo, Dairy Crest is an attractive growth platform for the company in the UK as Dairy Crest is expected to make its products from existing facilities in the country. Dairy Crest’s Country Life butter as well as Davidstow and Cathedral City cheese brands would complement Saputo’s cheese business which comprises Cheese Heads and Armstrong Cheese.

Remarkably, the deal comes at a time when Britain is only one month away from its exit from the European Union which is anticipated to create problems for the supply chains and raise prices of dairy products. In January, Dairy Crest has announced that it will be buying ingredients and packaging material to create a buffer to offset the effects of Brexit in spite of the company’s supply chain and customer base being primarily based in Britain.

Sources close to the matter suggest that the companies began their discussion in January 2019 and have moved rapidly. Dairy Crest plans to advise its shareholders to vote in favor of the deal as it considers the terms of the deal to be fair and reasonable.

According to sources, Dairy Crest has been shifting its focus and strategy to make its cheese and spreads business more profitable and therefore has been selling its dairy operations in 2014 when it suffered from the low milk prices in Britain. Saputo is reportedly one of the largest dairy companies in Canada and has been growing steadily through around 30 acquisition deals ever since it became a publicly traded company in 1997.

Saputo said that the deal will be funded by National Bank of Canada and Bank of Montréal who will provide debt under a fully underwritten credit agreement.

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

France might ban short domestic flights to reduce its carbon footprint

France might ban short domestic flights to reduce its carbon footprint

By Nikita Chaurasia

French lawmakers recently came to a unanimous decision to ban domestic flights for distances that can be covered by train in over two-and-a-half- hours. The country aims to impose these restrictions in an effort to reduce carbon emissions, even as th...

Kavak secures USD 485 million in funding, eyes Latin America expansion

Kavak secures USD 485 million in funding, eyes Latin America expansion

By Nikita Chaurasia

Kavak, a Mexico-based used-car platform, has reportedly reached a valuation of USD 4 billion after securing USD 485 million during a new funding round. This makes it the fastest-growing as well as the most valued company in Latin America. The latest...

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

By Nikita Chaurasia

Indian pharmaceutical company Zydus Cadila is reportedly seeking approval from DCGI (Drug Controller General of India) for its PegIFN (Pegylated Interferon Alpha-2b), a hepatitis C drug, to treat COVID-19 patients, after its third phase of clinical t...

LinkedIn confirms launch of a social audio platform to rival Clubhouse

LinkedIn confirms launch of a social audio platform to rival Clubhouse

By Nikita Chaurasia

LinkedIn, the popular employment-oriented online service, has confirmed that it is testing a social audio experience in its app which could offer users with better connectivity in their networks. Although several social media giants such as Twitter ...

Pfizer begins Phase-1 trials of oral COVID-19 antiviral drug in U.S.

Pfizer begins Phase-1 trials of oral COVID-19 antiviral drug in U.S.

By Nikita Chaurasia

Pfizer Inc., an American multinational pharmaceutical corporation, has recently announced to have started the early phase trials for its oral antiviral drug for Coronavirus. The company revealed that first phase trials of the experimental drug, PF-07...